An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy

NCT00938912 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

366

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

DRUG: Lacosamide
DRUG: Lacosamide

Sponsor

UCB BIOSCIENCES, Inc.